The drugs industry closed the day up 1.3%. Questcor Pharmaceuticals Inc ( QCOR), Tibet Pharmaceuticals Inc ( TBET), OxiGene Inc ( OXGN), and Abaxis Inc ( ABAX) were all winners today within the drugs industry with Pfizer Inc ( PFE) being today's featured drugs winner. Pfizer Inc rose 41 cents (2.2%) to $19.28 on light volume. Throughout the day, 36.7 million shares of Pfizer Inc exchanged hands as compared to its average daily volume of 53.3 million shares.

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Pfizer Inc has a market cap of $151 billion and is part of the health care sector. The company has a P/E ratio of 18.1, above the average drugs industry P/E ratio of 17.9 and above the S&P 500 P/E ratio of 17.7. Shares are up 7.8% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins, solid stock price performance and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, Albany Molecular Research Inc ( AMRI), Poniard Pharmaceuticals Inc ( PARD), Marina Biotech Inc ( MRNA), and K-V Pharmaceutical Company ( KV.B) were all losers within the drugs industry with Human Genome Sciences Inc ( HGSI) being today's drugs industry Loser Spotlight stock.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).